Phase III Trial Shows Promise for Hetlioz in Treating Delayed Sleep-Wake Phase Disorder
A late-stage clinical trial of Hetlioz (tasimelteon) demonstrated a significant advancement in sleep timing for adults with delayed sleep-wake phase disorder, moving sleep onset an average of 42.5…